Keith S. Pentlow

4.2k total citations · 1 hit paper
46 papers, 3.0k citations indexed

About

Keith S. Pentlow is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Keith S. Pentlow has authored 46 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Keith S. Pentlow's work include Radiopharmaceutical Chemistry and Applications (24 papers), Medical Imaging Techniques and Applications (23 papers) and Thyroid Cancer Diagnosis and Treatment (10 papers). Keith S. Pentlow is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (24 papers), Medical Imaging Techniques and Applications (23 papers) and Thyroid Cancer Diagnosis and Treatment (10 papers). Keith S. Pentlow collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Keith S. Pentlow's co-authors include Steven M. Larson, Ronald D. Finn, Martin C. Graham, L. N. Rothenberg, R. Michael Tuttle, Richard J. Robbins, John L. Humm, Rébecca Leboeuf, Ravinder K. Grewal and Ronald Ghossein and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Keith S. Pentlow

44 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

2013 555 citations Alan L. Ho, Ravinder K. Grewal et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith S. Pentlow United States	25	1.8k	978	599	438	369	46	3.0k
Heribert Hänscheid Germany	29	1.4k 0.8×	1.0k 1.1×	445 0.7×	736 1.7×	254 0.7×	102	2.8k
Klaus Zöphel Germany	29	1.3k 0.7×	380 0.4×	905 1.5×	404 0.9×	191 0.5×	108	2.4k
Françoise Kraeber‐Bodéré France	40	2.7k 1.5×	715 0.7×	1.0k 1.7×	1.4k 3.1×	713 1.9×	215	4.9k
Secondo Lastoria Italy	33	991 0.6×	574 0.6×	496 0.8×	1.3k 3.0×	581 1.6×	159	3.5k
James Nagarajah Germany	29	1.2k 0.7×	555 0.6×	856 1.4×	621 1.4×	298 0.8×	121	2.3k
Nicolas Aide France	29	1.6k 0.9×	204 0.2×	939 1.6×	678 1.5×	193 0.5×	107	2.8k
Peter Bernhardt Sweden	37	2.3k 1.3×	223 0.2×	931 1.6×	1.2k 2.6×	318 0.9×	130	3.8k
Francesco Scopinaro Italy	35	2.1k 1.2×	147 0.2×	892 1.5×	874 2.0×	301 0.8×	217	3.9k
T.A. DeWees United States	35	1.1k 0.6×	322 0.3×	1.7k 2.8×	808 1.8×	403 1.1×	174	3.9k
Jörg Kotzerke Germany	36	3.0k 1.7×	202 0.2×	1.9k 3.1×	870 2.0×	339 0.9×	181	4.8k

Countries citing papers authored by Keith S. Pentlow

Since Specialization

Citations

This map shows the geographic impact of Keith S. Pentlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith S. Pentlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith S. Pentlow more than expected).

Fields of papers citing papers by Keith S. Pentlow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith S. Pentlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith S. Pentlow. The network helps show where Keith S. Pentlow may publish in the future.

Co-authorship network of co-authors of Keith S. Pentlow

This figure shows the co-authorship network connecting the top 25 collaborators of Keith S. Pentlow. A scholar is included among the top collaborators of Keith S. Pentlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith S. Pentlow. Keith S. Pentlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burman, Bharat, R. Michael Tuttle, Ravinder K. Grewal, et al.. (2022). Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446).. Journal of Clinical Oncology. 40(16_suppl). 6089–6089. 4 indexed citations

Beattie, Bradley J., et al.. (2021). Optimizing reconstruction parameters for quantitative 124I-PET in the presence of therapeutic doses of 131I. EJNMMI Physics. 8(1). 50–50. 2 indexed citations

Pandit‐Taskar, Neeta, Pat Zanzonico, Kim Kramer, et al.. (2019). Biodistribution and Dosimetry of Intraventricularly Administered ¹²⁴I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors. Journal of Nuclear Medicine. 60(12). 1794–1801. 32 indexed citations

Beattie, Bradley J., Keith S. Pentlow, Joseph A. O’Donoghue, & John L. Humm. (2014). A Recommendation for Revised Dose Calibrator Measurement Procedures for 89Zr and 124I. PLoS ONE. 9(9). e106868–e106868. 19 indexed citations

Ho, Alan L., Ravinder K. Grewal, Rébecca Leboeuf, et al.. (2013). Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer. New England Journal of Medicine. 368(7). 623–632. 555 indexed citations breakdown →

Beattie, Bradley J., Daniel L.J. Thorek, C. Ross Schmidtlein, et al.. (2012). Quantitative Modeling of Cerenkov Light Production Efficiency from Medical Radionuclides. PLoS ONE. 7(2). e31402–e31402. 65 indexed citations

Grewal, Ravinder K., et al.. (2009). Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation. Journal of Nuclear Medicine. 50(10). 1605–1610. 97 indexed citations

Grewal, Ravinder K., Mark Lubberink, Keith S. Pentlow, & Steven M. Larson. (2007). The Role of Iodine-124-Positron Emission Tomography Imaging in the Management of Patients with Thyroid Cancer. PET Clinics. 2(3). 313–320. 12 indexed citations

Beattie, Bradley J., Ronald D. Finn, Douglas J. Rowland, & Keith S. Pentlow. (2003). Quantitative imaging of bromine‐76 and yttrium‐86 with PET: A method for the removal of spurious activity introduced by cascade gamma rays. Medical Physics. 30(9). 2410–2423. 55 indexed citations

10.

Graham, Martin C., Keith S. Pentlow, Osama Mawlawi, et al.. (1997). An investigation of the physical characteristics of ⁶⁶Ga as an isotope for PET imaging and quantification. Medical Physics. 24(2). 317–326. 31 indexed citations

11.

Cheung, Nai‐Kong V., Samuel D. J. Yeh, Farhad Daghighian, et al.. (1995). Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors. European Journal of Nuclear Medicine and Molecular Imaging. 22(5). 419–426. 15 indexed citations

12.

Rubin, Stephen C., Kalevi Kairemo, Farhad Daghighian, et al.. (1993). High-Resolution Positron Emission Tomography of Human Ovarian Cancer in Nude Rats Using 124I-Labeled Monoclonal Antibodies. Gynecologic Oncology. 48(1). 61–67. 20 indexed citations

13.

Rothenberg, L. N. & Keith S. Pentlow. (1992). Radiation dose in CT.. Radiographics. 12(6). 1225–1243. 149 indexed citations

14.

Finn, R., Chaitanya Divgi, Jean St. Germain, et al.. (1991). Technical challenges associated with the radiolabeling of monoclonal antibodies utilizing short-lived, positron emitting radionuclides. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(1). 9–13. 11 indexed citations

15.

Pentlow, Keith S., et al.. (1991). Quantitative imaging of I‐124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy. Medical Physics. 18(3). 357–366. 93 indexed citations

16.

Scheinberg, David A., Chaitanya Divgi, Martin C. Graham, et al.. (1991). A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.. Journal of Clinical Oncology. 9(3). 478–490. 188 indexed citations

17.

Scheinberg, David A., David J. Straus, Chaitanya Divgi, et al.. (1990). A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression.. Journal of Clinical Oncology. 8(5). 792–803. 74 indexed citations

18.

Goldenberg, Alec, et al.. (1989). Imaging of Human Tumor Xenografts With an Indium-111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal Antibody. JNCI Journal of the National Cancer Institute. 81(21). 1616–1625. 81 indexed citations

19.

White, D. R., et al.. (1979). A SURVEY OF 20 CT SYSTEMS. Journal of Computer Assisted Tomography. 3(4). 573–573. 1 indexed citations

20.

Pentlow, Keith S., David A. Rottenberg, & M. D. F. Deck. (1978). Partial volume summation: A simple approach to ventricular volume determination from CT. Neuroradiology. 16(1). 130–132. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact